BIOCEPT INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biocept Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2023.
  • Biocept Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $162K.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.87M, a 115% decline from 2021.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12.4M, a 51.9% decline from 2020.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $25.7M, a 13.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $162K +$430K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q1 2022 -$268K +$34K +11.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 -$302K -$17.8M -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q1 2020 $17.5M +$870K +5.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $16.6M +$3.86M +30.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $12.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.